In Silico Decoding of Nonsteroidal Mineralocorticoid Receptor Antagonist Binding: Implications for Drug Design
Journal of Chemical Information and Modeling · 2026
DOI: 10.1021/acs.jcim.6c00183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2026. Verfasst von Felipe Pérez-Gordillo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 6, Madrid28006, Spain. Hauptthemen laut MEDLINE: Mineralocorticoid Receptor Antagonists, Receptors, Mineralocorticoid, Drug Design. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, Consejo Superior de Investigaciones Cient?ficas, European Regional Development Fund.
Abstract (Originalsprache)
The mineralocorticoid receptor (MR), a member of the steroid hormone nuclear receptor subfamily, mediates the effects of aldosterone and glucocorticoids. Initially characterized in epithelial tissues as a key regulator of blood pressure, MR was later found to be widely expressed across multiple tissues, where it mediates processes such as inflammation, oxidative stress, and fibrosis. Accordingly, MR antagonists (MRAs) have important clinical applications beyond their diuretic effect, forming a cornerstone in the treatment of chronic heart failure and showing promise in conditions like diabetic nephropathy. Nonsteroidal MRAs typically show fewer off-target effects than their steroidal counterparts, although the risk of hyperkalemia─especially in patients with renal impairment─remains a concern. A detailed understanding of MRA-binding modes is therefore crucial for the development of improved therapeutics. To this end, we conducted an extensive computational study integrating induced fit docking (IFD) and molecular dynamics (MD) simulations across a comprehensive set of MRAs. This approach highlights key interactions responsible for binding affinity and offers insights into the molecular basis of selectivity and antagonism. Moreover, MD simulations revealed a potential link between the ligand interaction with Trp806 and coregulator recruitment. These findings provide a valuable foundation for in silico rational design of next-generation MRAs with enhanced safety and efficacy profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 6, Madrid28006, Spain.
- MolDrug AI Systems SL, Parque Tecnológico de Valencia, Valencia46980, Spain.
- Universidad de La Laguna , La Laguna382000, Spain.
ORCID-Profile: Diego Alvarez de la Rosa, Mercedes Martín-Martínez
Förderung
- Ministerio de Ciencia, Innovaci?n y Universidades
- Consejo Superior de Investigaciones Cient?ficas
- European Regional Development Fund
Zitieren
APA
Pérez-Gordillo, F., Carpio, L. E., Alvarez de la Rosa, D., & Martín-Martínez, M. (2026). In Silico Decoding of Nonsteroidal Mineralocorticoid Receptor Antagonist Binding: Implications for Drug Design. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.6c00183
Vancouver
Pérez-Gordillo F, Carpio LE, Alvarez de la Rosa D, Martín-Martínez M. In Silico Decoding of Nonsteroidal Mineralocorticoid Receptor Antagonist Binding: Implications for Drug Design. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.6c00183
BibTeX
@article{PrezGordillo2026,
author = {Pérez-Gordillo, Felipe and Carpio, Laureano E and Alvarez de la Rosa, Diego and Martín-Martínez, Mercedes},
title = {In Silico Decoding of Nonsteroidal Mineralocorticoid Receptor Antagonist Binding: Implications for Drug Design},
journal = {Journal of Chemical Information and Modeling},
year = {2026},
doi = {10.1021/acs.jcim.6c00183}
}
EUVIMED